Product correctly added to cart.

discount label
NFkB p65 antibody
View 3D

Biosynth logo

NFkB p65 antibody

Ref. 3D-70R-37452

100µg
456.00 €
Estimated delivery in United States, on Monday 13 Jan 2025

Product Information

Name:
NFkB p65 antibody
Description:

The NFkB p65 antibody is a highly specialized monoclonal antibody used in Life Sciences research. It specifically targets the epidermal growth factor (EGF) and has been shown to inhibit endonuclease activity associated with EGF-like molecules.

This antibody is widely used in studies involving microvessel density, as it has been found to neutralize the effects of hyaluronidase, an enzyme that degrades hyaluronic acid, a major component of the extracellular matrix. By inhibiting hyaluronidase activity, the NFkB p65 antibody helps maintain the integrity of blood vessels and supports normal angiogenesis processes.

Furthermore, this antibody has a high affinity for the amino-terminal region of apolipoprotein A-I (apoA-I), a key protein involved in cholesterol metabolism. By binding to apoA-I, the NFkB p65 antibody can modulate its function and potentially influence lipid homeostasis.

The NFkB p65 antibody is available as both

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-70R-37452 NFkB p65 antibody

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".